OXavidin for Tissue Targeting Biotinylated Therapeutics

Figure 4

Immunohistochemistry of avidin (a,c) or OXavidin (b,d) injected normal muscle (a,b) or MDA-MB-468 human breast carcinoma xenotransplanted mass (c,d) 48 hours after injection.

(a)

(b)

(c)

(d)